TNF-?/IL-17 synergy inhibits IL-13 bioactivity via IL-13R?2 induction - 02/10/14
This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. T. Ort is an employee of Johnson and Johnson. L.A.B. is funded by a European Union FP7 Marie Curie fellowship (grant no. 275781). |
|
Disclosure of potential conflict of interest: T. Ort is employed by Janssen R&D. A. Fisher's institution has received or has grants pending from MedImmune. L. A. Borthwick is employed by Newcastle University, which has received funding from the European Union Research Fellowship Programme. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 134 - N° 4
P. 975 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?